The mckinsey opioid lawsuit targets one of the world’s largest consulting firms, not a drugmaker. Plaintiffs allege McKinsey & Company helped fuel the opioid crisis. For example, they say the firm advised Purdue Pharma to “turbocharge” OxyContin sales. This litigation matters because it holds a corporate advisor accountable, not just a manufacturer. As a result, governments, insurers, and injured individuals have all pursued claims. This page explains the case in plain terms.
Case Timeline
Last checked: September 03, 2026
What Is the Mckinsey Opioid Lawsuit About?
The mckinsey opioid lawsuit centers on marketing advice, not pill production. McKinsey consulted for major opioid makers, including Purdue Pharma. Plaintiffs claim the firm designed strategies to boost prescriptions. For example, they allege McKinsey pushed for more sales calls to high-volume prescribers. Critics say this advice downplayed clear safety warnings.
The alleged conduct helped drive widespread opioid use. Typically, that overprescribing led to addiction, overdose, and death. Communities absorbed the costs of treatment and emergency response. Families lost loved ones. Babies were born dependent on opioids, a condition called neonatal abstinence syndrome.
The defendant here is McKinsey itself. Unlike the broader national opioid case, this litigation focuses on the consultant’s role. However, the underlying harm mirrors the wider opioid epidemic documented by the CDC. Plaintiffs argue the firm profited while helping expand a dangerous market.
MDL Case Status and Key Facts
| MDL Detail | Current Data |
|---|---|
| MDL Number | MDL-2996 |
| Pending Cases | 235 |
| Presiding Judge | Charles R. Breyer |
| Federal District | CAN |
| Data Source | U.S. Judicial Panel on Multidistrict Litigation |
| Last Updated | August 03, 2026 |
Federal cases against McKinsey were consolidated into a multidistrict litigation, or MDL. This groups similar lawsuits before one judge for efficiency. The Judicial Panel created a separate MDL for these claims in 2021. It kept them apart from the older national opioid MDL-2804.
| Detail | Information |
|---|---|
| MDL Number | MDL-2996 |
| Case Name | In re: McKinsey & Company, Inc., National Prescription Opiate Consultant Litigation |
| Presiding Judge | Hon. Charles R. Breyer |
| Federal District | Northern District of California |
| Approximate Case Count | 235 |
| Bellwether Trials | None scheduled as of mid-2026 |
Judge Charles R. Breyer oversees the MDL. He previously handled a key San Francisco opioid case. As a result, he brings deep experience to these proceedings. That background shapes how the court manages complex claims.
The MDL remains active in 2026. However, several major class settlements have already resolved large groups of claims. Individual and government tracks have moved at different speeds. Some claims were dismissed, while others settled.
Who Qualifies for the Mckinsey Opioid Lawsuit?
Eligibility for the mckinsey opioid lawsuit depends on who you are and how you were harmed. Several distinct groups have pursued claims. These include government entities, insurers, and injured individuals. Each track has different rules.
Political subdivisions, such as counties, cities, and school districts, formed one class. They sought money for public costs tied to the crisis. Third-party payors, like insurers and benefit plans, formed another. For example, they paid for opioids and later addiction treatment.
Individuals who suffered personal injury may also have claims. Typically, this includes people who became addicted after opioid prescriptions. It may include families who lost a loved one to overdose. However, a class for babies with neonatal abstinence syndrome was dismissed for failing to state a claim. Helpful evidence includes prescription records, medical bills, and treatment history. An attorney can review whether your situation fits.
How to File a Mckinsey Opioid Lawsuit Claim
Filing a mckinsey opioid lawsuit claim starts with legal advice. First, consult a licensed attorney who handles mass tort cases. Most offer free initial reviews. They can assess your documents and injuries. As a result, you avoid guessing about eligibility.
Next, your lawyer gathers evidence. Typically, this means prescription records, pharmacy history, and medical files. In an MDL, plaintiffs often complete a plaintiff fact sheet. This form collects details about your exposure and harm. It helps the court organize many claims at once.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Timing matters greatly. Every state sets a statute of limitations, a deadline to sue. However, these deadlines vary widely by state and claim type. If a class settlement applies, its claim forms carry their own deadlines. For example, missing a settlement filing window can end your recovery. As a result, act early rather than waiting.
Settlement Updates and What to Expect
McKinsey has resolved several parts of this litigation. Earlier, the firm agreed to a roughly $600 million deal with state attorneys general. Later, a large fund was approved for political subdivisions and school districts. Judge Breyer granted final approval in 2024.
A separate settlement addressed third-party payors, such as insurers and benefit plans. That deal also received final approval in 2024. In total, McKinsey has paid close to $1 billion across its opioid-related settlements. However, these figures reflect group funds, not individual payouts.
What any single person receives varies. Payment depends on injury severity, documentation, and the specific settlement class. Class funds are divided among many claimants. As a result, no one can promise a set amount. You may qualify for compensation, but nothing is guaranteed. An attorney can explain realistic expectations for your claim.
State-by-State Considerations
State law shapes how these claims proceed. Tort reform rules differ across the country. For example, some states cap certain damages or set shorter deadlines. These differences affect timing and value. In most cases, your home state’s law governs your personal injury claim.
Hard-hit states saw heavy participation from local governments. For example, California, Ohio, West Virginia, Kentucky, and Florida reported significant opioid burdens. Subdivisions in these states joined the funds in large numbers. However, individual eligibility still turns on your own records. Review our state guides and consult a local attorney for specifics.
Frequently Asked Questions
Is McKinsey a drugmaker in this case?
No. McKinsey is a consulting firm. Plaintiffs allege it advised opioid makers on aggressive marketing. The mckinsey opioid lawsuit focuses on that advisory role, not on manufacturing pills.
Can individuals still file claims?
Possibly. Some class settlements have closed for certain groups, while other claims continue. Deadlines vary by state and by settlement. Speak with a licensed attorney promptly to check your options.
How much money will I get?
It varies. Payouts depend on your injuries, evidence, and the applicable settlement class. No one can guarantee an amount. You may qualify, but an attorney should review your specific situation first.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- U.S. Judicial Panel on Multidistrict Litigation (JPML)
- U.S. Department of Justice
- FDA Safety Alerts & Recalls
- Centers for Disease Control and Prevention
- U.S. Environmental Protection Agency
Content last reviewed July 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Texas Tort Reform Guide
- Illinois Tort Reform Guide
- North Carolina Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.